Brief: Shield Therapeutics Remains On Track To Be Cash Flow Positive By End Of 2025
17/04/2025 11:23
April 17 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS PLC: REMAINS ON TRACK TO BE CASH FLOW POSITIVE BY END OF 2025 Source text: ID:nRSQ4930Fa Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update